<doc>
  <docmeta id="113hr1102ih">
    <bill congress="113" type="hr" number="1102" version="ih"/>
    <revision size="3930" annotations="0" id="10" commit-time="2013-04-03T21:43:55+00:00" committer="favila" doc="113hr1102ih/10.xml" status="complete">
      <description/>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" dms-id="HC173F4C21ECD4BFE928381791E969967" public-private="public" bill-type="olc"> 
<metadata>
<dublinCore>
<title>113 HR 1102 IH: Medicare Prescription Drug Price Negotiation Act of 2013</title>
<publisher>U.S. House of Representatives</publisher>
<date>2013-03-12</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>113th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 1102</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20130312">March 12, 2013</action-date> 
<action-desc>
        <sponsor name-id="W000800">Mr. Welch</sponsor> (for himself, <cosponsor name-id="C001066">Ms. Castor of Florida</cosponsor>, <cosponsor name-id="C001084">Mr. Cicilline</cosponsor>, <cosponsor name-id="C000714">Mr. Conyers</cosponsor>, <cosponsor name-id="E000288">Mr. Ellison</cosponsor>, <cosponsor name-id="C001049">Mr. Clay</cosponsor>, <cosponsor name-id="M001160">Ms. Moore</cosponsor>, <cosponsor name-id="S000480">Ms. Slaughter</cosponsor>, <cosponsor name-id="Y000062">Mr. Yarmuth</cosponsor>, <cosponsor name-id="M001149">Mr. Michaud</cosponsor>, and <cosponsor name-id="S001145">Ms. Schakowsky</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.</official-title> 
</form> 
<legis-body id="H1FCA3FC81F67417295D4B2254094B181" style="OLC"> 
<section id="H8EDB6A6A2370414FA7D7E378DF9ADC1D" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>Medicare Prescription Drug Price Negotiation Act of 2013</short-title>
        </quote>.</text>
    </section> 
<section id="HA8E8F00270544F7787938ACFB00150E5">
      <enum>2.</enum>
      <header>Negotiation of lower covered part D drug prices on behalf of medicare beneficiaries</header> 
<subsection id="H30F6E3E5461F4F3C836B213287818143">
        <enum>(a)</enum>
        <header>Negotiation by secretary</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–11">Section 1860D–11 of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-111">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395w–111">42 U.S.C. 1395w–111</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D-11/ss:i">subsection (i)</cato:entity-ref> (relating to noninterference) and inserting the following:</text> 
<quoted-block id="HB737CD1271E942C89F56AC8329B4B1D4" style="OLC"> 
<subsection id="HB00206A92A9A4F1383B693BC5E7B80F9">
            <enum>(i)</enum>
            <header>Negotiation of Lower Drug Prices</header> 
<paragraph id="H35434E8E7C9745F5BA39C1906B06F787">
              <enum>(1)</enum>
              <header>In general</header>
              <text>Notwithstanding any other provision of law, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall negotiate with pharmaceutical manufacturers the prices (including discounts, rebates, and other price concessions) that may be charged to PDP sponsors and MA organizations for covered part D drugs for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan.</text>
            </paragraph> 
<paragraph id="HEF1E6B0295E74193AA95303A3F767DC9">
              <enum>(2)</enum>
              <header>No change in rules for formularies</header> 
<subparagraph id="H4F5FCF5D8F86451CB108A9C0AFEA39E3">
                <enum>(A)</enum>
                <header>In general</header>
                <text>Nothing in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D-11/ss:i/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall be construed to authorize the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to establish or require a particular formulary.</text>
              </subparagraph> 
<subparagraph id="H971F0DDA808E494FB505A626EE82F5F7">
                <enum>(B)</enum>
                <header>Construction</header>
                <text>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D-11/ss:i/p:2/sp:A" proposed="true">Subparagraph (A)</cato:entity-ref> shall not be construed as affecting the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary's</cato:entity-ref> authority to ensure appropriate and adequate access to covered part D drugs under prescription drug plans and under MA–PD plans, including compliance of such plans with formulary requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:b/p:3">section 1860D–4(b)(3)</cato:entity-ref>.</text>
              </subparagraph>
            </paragraph> 
<paragraph id="H7FB2317E2A674243ADC453AA5775A354">
              <enum>(3)</enum>
              <header>Construction</header>
              <text>Nothing in this subsection shall be construed as preventing the sponsor of a prescription drug plan, or an organization offering an MA–PD plan, from obtaining a discount or reduction of the price for a covered part D drug below the price negotiated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D-11/ss:i/p:1" proposed="true">paragraph (1)</cato:entity-ref>.</text>
            </paragraph> 
<paragraph id="H5BEE8549102D47C29BAA90422B65909A">
              <enum>(4)</enum>
              <header>Semi-annual reports to congress</header>
              <text>Not later than June 1, 2014, and every 6 months thereafter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HWM00">Committees on Ways and Means</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HIF00">Energy and Commerce</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HGO00">Oversight and Government Reform of the House of Representatives</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="SSFI00">Committee on Finance of the Senate</cato:entity-ref> a report on negotiations conducted by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to achieve lower prices for Medicare beneficiaries, and the prices and price discounts achieved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> as a result of such negotiations.</text>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection> 
<subsection id="HC864E08CA5C44CAAA1907175DA603380">
        <enum>(b)</enum>
        <header>Effective date</header>
        <text>The amendment made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Medicare Prescription Drug Price Negotiation Act of 2013/s:2/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall take effect on the date of the enactment of this Act and shall first apply to negotiations and prices for plan years beginning on January 1, 2014.</text>
      </subsection>
    </section> 
</legis-body> 
</bill>
</doc>